Chemistry & Biology Article Neural Crest Development and Craniofacial Morphogenesis Is Coordinated by Nitric Oxide and Histone Acetylation Yawei Kong,1,2,3 Michael Grimaldi,1,2,3 Eugene Curtin,1,2 Max Dougherty,1,2 Charles Kaufman,4 Richard M. White,4 Leonard I. Zon,4,5 and Eric C. Liao1,2,3,5,* 1Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA 2Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA 3Shriners Hospitals for Children, Boston, MA 02114, USA 4Howard Hughes Medical Institute, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115, USA 5Harvard Stem Cell Institute, Boston, MA 02114, USA *Correspondence:
[email protected] http://dx.doi.org/10.1016/j.chembiol.2014.02.013 SUMMARY cial development. Genetic mutations affecting histone acetyla- tion (MYST4), demethylation (KDM6A, PHF8), and sumoylation Cranial neural crest (CNC) cells are patterned and (SUMO1) result in orofacial clefts (Alkuraya et al., 2006; Fischer coalesce to facial prominences that undergo conver- et al., 2006; Kraft et al., 2011; Qi et al., 2010). Further, epigenetic gence and extension to generate the craniofacial mechanisms may explain variability in phenotypic penetrance of form. We applied a chemical genetics approach to genetic mutations that affect craniofacial development and identify pathways that regulate craniofacial develop- mediation of environmental factors. ment during embryogenesis. Treatment with the Histone acetylation is catalyzed by histone acetyltransferases (HATs), which transfer acetyl groups to lysines in the tails of core nitric oxide synthase inhibitor 1-(2-[trifluoromethyl] histone (Marmorstein and Roth, 2001).